BDBM454781 (1R,2S)-2-((5-fluoro-2-(2-methoxy-7-methylquinoxalin-5-yl)benzo[d]thiazol-6-yl)ox y)cyclopentyl (6-carbamoylpyridin-3-yl)carbamate::US10730868, Ex. No. 49

SMILES COc1cnc2c(cc(C)cc2n1)-c1nc2cc(F)c(O[C@H]3CCC[C@H]3OC(=O)Nc3ccc(nc3)C(N)=O)cc2s1

InChI Key InChIKey=UNSKGFQCEVDQBL-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 454781   

TargetProteinase-activated receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454781((1R,2S)-2-((5-fluoro-2-(2-methoxy-7-methylquinoxal...)
Affinity DataIC50: 3.60nMAssay Description:FLIPR-based calcium mobilization assay in HEK293 cells was used to measure PAR4 antagonism agonism, and selectivity against PAR1. The activity of the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2021
Entry Details
US Patent